Huntingtin and Huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

被引:381
作者
Tang, TS
Tu, HP
Chan, EYW
Maximov, A
Wang, ZN
Wellington, CL
Hayden, MR
Bezprozvanny, I [1 ]
机构
[1] Univ Texas, Dept Physiol, SW Med Ctr, Dallas, TX 75390 USA
[2] Univ Texas, Ctr Basic Neurosci, SW Med Ctr, Dallas, TX 75390 USA
[3] Womens & Childrens Hosp, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1016/S0896-6273(03)00366-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is caused by polyglutamine expansion (exp) in huntingtin (Htt). The type 1 inositol (1,4,5)-triphosphate receptor (InsP(3)R1) is an intracellular calcium (Call) release channel that plays an important role in neuronal function. In a yeast two-hybrid screen with the InsP3R1 carboxy terminus, we isolated Htt-associated protein-1A (HAP1A). We show that an lnsP(3)R1 -HAP1A-Htt ternary complex is formed in vitro and in vivo. In planar lipid bilayer reconstitution experiments, InsP(3)R1 activation by InsP(3) is sensitized by Htt(exp), but not by normal Htt. Transfection of full-length Htt(exp) or caspase-resistant Htt(exp), but not normal Htt, into medium spiny striatal neurons faciliates Ca2+ release in response to threshold concentrations of the selective mGluR1/5 agonist 3,5-DHPG. Our findings identify a novel molecular link between Htt and InsP(3)R1-mediated neuronal Ca2+ signaling and provide an explanation for the derangement of cytosolic Call signaling in HD patients and mouse models.
引用
收藏
页码:227 / 239
页数:13
相关论文
共 63 条
  • [31] A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES
    MACDONALD, ME
    AMBROSE, CM
    DUYAO, MP
    MYERS, RH
    LIN, C
    SRINIDHI, L
    BARNES, G
    TAYLOR, SA
    JAMES, M
    GROOT, N
    MACFARLANE, H
    JENKINS, B
    ANDERSON, MA
    WEXLER, NS
    GUSELLA, JF
    BATES, GP
    BAXENDALE, S
    HUMMERICH, H
    KIRBY, S
    NORTH, M
    YOUNGMAN, S
    MOTT, R
    ZEHETNER, G
    SEDLACEK, Z
    POUSTKA, A
    FRISCHAUF, AM
    LEHRACH, H
    BUCKLER, AJ
    CHURCH, D
    DOUCETTESTAMM, L
    ODONOVAN, MC
    RIBARAMIREZ, L
    SHAH, M
    STANTON, VP
    STROBEL, SA
    DRATHS, KM
    WALES, JL
    DERVAN, P
    HOUSMAN, DE
    ALTHERR, M
    SHIANG, R
    THOMPSON, L
    FIELDER, T
    WASMUTH, JJ
    TAGLE, D
    VALDES, J
    ELMER, L
    ALLARD, M
    CASTILLA, L
    SWAROOP, M
    [J]. CELL, 1993, 72 (06) : 971 - 983
  • [32] Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors
    Mao, LM
    Wang, JQ
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (03) : 473 - 484
  • [33] Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons
    Mao, LM
    Wang, JQ
    [J]. MOLECULAR BRAIN RESEARCH, 2001, 86 (1-2): : 125 - 137
  • [34] Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor
    Matsumoto, M
    Nakagawa, T
    Inoue, T
    Nagata, E
    Tanaka, K
    Takano, H
    Minowa, O
    Kuno, J
    Sakakibara, S
    Yamada, M
    Yoneshima, H
    Miyawaki, A
    Fukuuchi, Y
    Furuichi, T
    Okano, H
    Mikoshiba, K
    Noda, T
    [J]. NATURE, 1996, 379 (6561) : 168 - 171
  • [35] Apoptosis in neurodegenerative disorders
    Mattson, MP
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (02) : 120 - 129
  • [36] Dysregulation of cellular calcium homeostasis in Alzheimer's disease - Bad genes and bad habits
    Mattson, MP
    Chan, SL
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 17 (02) : 205 - 224
  • [37] Association of the type 1 inositol (1,4,5)-trisphosphate receptor with 4.1N protein in neurons
    Maximov, A
    Tang, TS
    Bezprozvanny, I
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2003, 22 (02) : 271 - 283
  • [38] Maximov A, 2002, J NEUROSCI, V22, P6939
  • [39] Mouse models of Huntington's disease
    Menalled, LB
    Chesselet, MF
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (01) : 32 - 39
  • [40] MIGNERY GA, 1990, J BIOL CHEM, V265, P12679